← Every firm
Aurolife Pharma, LLC FDA Recalls
3 recalls on file across drugs, 0 of them Class I and 1 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor,Class IIIMay 18, 2023Failed Impurities/Degradation Specifications |
| Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08Class IIDec 16, 2022Failed Impurities/Degradation Specifications |
| Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Class IIMar 17, 2022Presence of Foreign Substance: Complaint for pieces of glass |